Paper36901633
Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy-A Cross-Sectional Study in Patients with Type 2 Diabetes.
Luo WM and 3 others. Int J Environ Res Public Health, 2023. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy-A Cross-Sectional Study in Patients with Type 2 Diabetes. Papers, record 36901633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901633
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy-A Cross-Sectional Study in Patients with Type 2 Diabetes.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Nephropathies | Major topic |
| Diabetic Retinopathy | Major topic |
| Humans | |
| Cross-Sectional Studies | |
| Prevalence | |
| Hypoglycemic Agents | |
| Risk Factors |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32883686 | Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes. | BMJ Open Diabetes Res Care | 2020 | https://conductscience.org/library/papers/32883686 | PubMed |
| 2 | 2079312 | Acarbose treatment and diabetic nephropathy in the Cohen diabetic rat. | Horm Metab Res | 1990 | https://conductscience.org/library/papers/2079312 | PubMed |
| 3 | 34469084 | The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease. | G Ital Nefrol | 2021 | https://conductscience.org/library/papers/34469084 | PubMed |
| 4 | 29728717 | Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial. | Diabetologia | 2018 | https://conductscience.org/library/papers/29728717 | PubMed |
| 5 | 24534450 | Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus. | Clin Chim Acta | 2014 | https://conductscience.org/library/papers/24534450 | PubMed |
| 6 | 2969913 | Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy. | J Diabet Complications | 1987 | https://conductscience.org/library/papers/2969913 | PubMed |
| 7 | 32267079 | An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. | Diabetes Obes Metab | 2020 | https://conductscience.org/library/papers/32267079 | PubMed |
| 8 | 31129667 | Diabetic Retinopathy in the Context of Patients with Diabetes. | Ophthalmic Res | 2019 | https://conductscience.org/library/papers/31129667 | PubMed |
| 9 | 27382338 | The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies. | Clin Pharmacol | 2016 | https://conductscience.org/library/papers/27382338 | PubMed |
| 10 | 12774164 | Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. | Diabetologia | 2003 | https://conductscience.org/library/papers/12774164 | PubMed |
| 11 | 20488910 | Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. | BMJ | 2010 | https://conductscience.org/library/papers/20488910 | PubMed |
| 12 | 31505379 | Predicting the onset of type 2 diabetes using wide and deep learning with electronic health records. | Comput Methods Programs Biomed | 2019 | https://conductscience.org/library/papers/31505379 | PubMed |
| 13 | 28432319 | Diabetic Retinopathy and Clinical Parameters Favoring the Presence of Diabetic Nephropathy could Predict Renal Outcome in Patients with Diabetic Kidney Disease. | Sci Rep | 2017 | https://conductscience.org/library/papers/28432319 | PubMed |
| 14 | 10867532 | Effect of acarbose on blood glucose and proteinuria in patients with diabetic nephropathy. | Nephron | 2000 | https://conductscience.org/library/papers/10867532 | PubMed |
| 15 | 33633688 | The Association Between Leucine and Diabetic Nephropathy in Different Gender: A Cross-Sectional Study in Chinese Patients With Type 2 Diabetes. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33633688 | PubMed |
| 16 | 23093684 | Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. | Diabetes Care | 2012 | https://conductscience.org/library/papers/23093684 | PubMed |
| 17 | 19804622 | The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study. | BMC Endocr Disord | 2009 | https://conductscience.org/library/papers/19804622 | PubMed |
| 18 | 23424866 | [Effect of the folic acid and vitamin B2 on the diabetes mellitus rats with diabetic nephropathy]. | Wei Sheng Yan Jiu | 2012 | https://conductscience.org/library/papers/23424866 | PubMed |
| 19 | 33478336 | The predictive value of diabetic retinopathy on subsequent diabetic nephropathy in patients with type 2 diabetes: a systematic review and meta-analysis of prospective studies. | Ren Fail | 2021 | https://conductscience.org/library/papers/33478336 | PubMed |
| 20 | 11733625 | Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. | Nephrol Dial Transplant | 2001 | https://conductscience.org/library/papers/11733625 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41821728 | Changes of retinal microvascular parameters in patients with type 2 diabetes mellitus with or without diabetic kidney disease. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41821728 | PubMed |
| 40385017 | Predictive value of liver and kidney function and bone metabolism markers for postoperative outcomes in diabetic retinal surgery. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/40385017 | PubMed |
| 38275038 | Diabetic Retinopathy Leading to Blindness- A Review. | Curr Diabetes Rev | 2024 | https://conductscience.org/library/papers/38275038 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOXO1 | 2308 | PubTator's text mining | https://conductscience.org/library/genes/2308 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| PRKAA1 | 5562 | PubTator's text mining | https://conductscience.org/library/genes/5562 | NCBI Gene |
| SIRT1 | 23411 | PubTator's text mining | https://conductscience.org/library/genes/23411 | NCBI Gene |
| SNAI1 | 6615 | PubTator's text mining | https://conductscience.org/library/genes/6615 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36901633
GET https://conductscience.org/api/papers/v1/36901633/references?page=2